ReviewCNS drugs2002

Potential of beta2-adrenoceptor agonists as add-on therapy for multiple sclerosis: focus on salbutamol (albuterol).

Karim Makhlouf et al.PubMed ↗Publisher ↗

No numbers read from the abstract.